He said the deal would be finalized in the coming weeks. That is apart from two existing orders of 100 million doses each for the vaccine developed by Oxford University and AstraZeneca, and another one from Novovax. Poonawalla said that Serum Institute was in the process of signing a larger contract with COVAX for 300 million-400 million doses of the vaccine. As a result, he said, the export of vaccines for COVAX - the ambitious initiative created to ensure equitable access to COVID-19 vaccines set up by the World Health Organization, vaccines alliance GAVI and CEPI, a global coalition to fight epidemics - won't begin until March or April.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |